Please check your internet connection and try again.
# Ecospirin Enteric-Coated Aspirin
## Overview
Ecospirin is an enteric-coated formulation of aspirin (acetylsalicylic acid), a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, and antiplatelet properties. The enteric coating is designed to delay the release of aspirin until it reaches the small intestine, potentially reducing gastric irritation.
## Primary Indications
* **Cardiovascular Prophylaxis:** Prevention of cardiovascular events (e.g., myocardial infarction, stroke) in patients with established cardiovascular disease or at high risk.
* **Analgesia and Antipyresis:** Relief of mild to moderate pain and fever. (Less common indication for the enteric-coated formulation due to slower onset).
* **Inflammatory Conditions:** Management of inflammatory conditions like rheumatoid arthritis, osteoarthritis, and other rheumatic disorders. (Higher doses typically required).
## Adult Dosing
Dosing varies significantly based on indication:
* **Cardiovascular Prophylaxis:** Typically 75 mg to 162 mg once daily. Lower doses (e.g., 75-100 mg) are often preferred for long-term secondary prevention.
* **Analgesia/Antipyresis:** 325 mg to 650 mg every 4 to 6 hours as needed. Maximum daily dose generally 4000 mg.
* **Inflammatory Conditions:** 2400 mg to 4000 mg per day, divided into 3 or 4 doses.
*Note: Specific dosing for cardiovascular prophylaxis may vary based on local guidelines and physician preference.*
## Pediatric Dosing
* **Fever and Pain:** Generally **not recommended** in children and adolescents under 19 years of age due to the risk of Reye's syndrome, especially during viral illnesses. If absolutely necessary and no alternatives exist, dosing is typically based on weight: 10-15 mg/kg/dose every 4-6 hours. Maximum daily dose 60-80 mg/kg/day.
* **Inflammatory Conditions (e.g., Kawasaki disease, juvenile idiopathic arthritis):** Dosing is highly specialized and determined by a pediatric rheumatologist, often in the range of 30-100 mg/kg/day in divided doses.
## Dose Adjustments
* **Renal Impairment:** Use with caution. Dose reduction may be necessary in severe renal impairment.
* **Hepatic Impairment:** Use with caution. Dose reduction may be necessary in severe hepatic impairment.
## Contraindications
* Hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* Active peptic ulcer disease or gastrointestinal bleeding.
* History of aspirin-induced asthma or urticaria.
* Children and adolescents with viral infections (risk of Reye's syndrome).
* Severe renal or hepatic impairment.
* Hemophilia and other bleeding disorders.
* Third trimester of pregnancy.
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, vomiting, abdominal pain, gastritis, peptic ulceration, GI bleeding.
* **Hematologic:** Increased bleeding time, bruising, epistaxis, petechiae.
* **Hypersensitivity:** Bronchospasm (especially in aspirin-sensitive asthma), urticaria, angioedema.
* **Other:** Tinnitus (especially at higher doses), dizziness, headache, confusion, Reye's syndrome (in children/adolescents with viral illness).
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding. Monitor INR/aPTT closely; consider dose adjustment or avoidance.
* **Other NSAIDs/COX-2 Inhibitors:** Increased risk of GI toxicity, renal toxicity, and bleeding. Concurrent use generally not recommended.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, diuretics):** May reduce antihypertensive efficacy and increase risk of renal impairment.
* **Methotrexate:** Increased methotrexate toxicity due to decreased renal clearance.
* **Sulfonylureas:** May potentiate hypoglycemic effects.
* **Uricosuric agents (e.g., probenecid):** Aspirin can antagonize the uricosuric effect.
* **Valproic acid:** Aspirin can displace valproic acid from protein-binding sites, increasing free valproic acid levels.
## Monitoring
* **GI Bleeding:** Monitor for signs and symptoms of GI bleeding (e.g., melena, hematemesis, abdominal pain).
* **Bleeding Risk:** Monitor for signs of increased bleeding (e.g., bruising, petechiae, prolonged bleeding from cuts).
* **Renal Function:** Monitor serum creatinine and BUN, especially in patients with pre-existing renal disease or those taking concomitant nephrotoxic agents.
* **Hepatic Function:** Monitor liver enzymes, particularly with chronic high-dose use.
* **Tinnitus:** Can be an early sign of salicylate toxicity.
## Clinical Pearls
* The enteric coating delays absorption, which can be beneficial for reducing gastric upset but may lead to a slower onset of action for pain and fever relief compared to non-coated aspirin.
* For acute pain or fever, non-enteric coated formulations are generally preferred.
* Always counsel patients about the risk of Reye's syndrome and to avoid aspirin in children/adolescents with viral illnesses.
* Low-dose aspirin for cardiovascular prophylaxis should be taken consistently as prescribed.
* Discontinue aspirin at least 5-7 days prior to elective surgery, if feasible, after consulting with the surgical team.
***
**Disclaimer:** This information is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified healthcare provider to determine the appropriate use of this medication and to review the most current prescribing information.
